The Patient Journey in Facial Aesthetics: Findings from a European Consensus Meeting on Improving the Quality of Life for Patients Receiving Botulinum Toxin Injections

References

• Blasi J, Chapman ER, Link E, et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 1993;365(6442):160–163. doi:10.1038/365160a0
   PubMed Web of Science ®Google Scholar
• Burgen AS, Dickens F, Zatman LJ. The action of botulinum toxin on the neuro-muscular junction. J Physiol. 1949;109(1–2):10–24. doi:10.1113/jphysiol.1949.sp004364
   PubMed Web of Science ®Google Scholar
• Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 2014;90(3):168–175.
   PubMed Web of Science ®Google Scholar
• Satriyasa BK. Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. Clin Cosmet Invest Dermatol. 2019;12:223–228. doi:10.2147/CCID.S202919
   PubMed Web of Science ®Google Scholar
• Carruthers A, Carruthers JDA. Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles. In: Jankovic J, Hallett M, editors. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc.; 1994:577–595.
   Google Scholar
• Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17–21. doi:10.1111/j.1524-4725.1992.tb03295.x
   PubMedGoogle Scholar
• Botox [summary of product characteristics]. Bucks, UK: Allergan; 2020.
   Google Scholar
• Finn JC, Cox SE, Earl ML. Social implications of hyperfunctional facial lines. Dermatol Surg. 2003;29(5):450–455. doi:10.1097/00042728-200305000-00003
   PubMed Web of Science ®Google Scholar
• Dayan S, Yoelin SG, De Boulle K, Garcia JK. The psychological impacts of upper facial lines: a qualitative, patient-centered study. Aesthet Surg J Open Forum. 2019;1(2):1–10. doi:10.1093/asjof/ojz015
   Google Scholar
• Gupta MA, Gilchrest BA. Psychosocial aspects of aging skin. Dermatol Clin. 2005;23(4):643–648. doi:10.1016/j.det.2005.05.012
   PubMed Web of Science ®Google Scholar
• Cohen JL, Rivkin A, Dayan S, et al. Multimodal facial aesthetic treatment on the appearance of aging, social confidence, and psychological wellbeing: HARMONY study. Aesthet Surg J. 2022;42(2):NP115–NP124. doi:10.1093/asj/sjab114
   PubMed Web of Science ®Google Scholar
• Dayan S, Rivkin A, Sykes JM, et al. Aesthetic treatment positively impacts social perception: analysis of subjects from the HARMONY study. Aesthet Surg J. 2019;39(12):1380–1389. doi:10.1093/asj/sjy239
   PubMed Web of Science ®Google Scholar
• Dayan SH, Arkins JP, Patel AB, Gal TJ. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type A injections on quality of life and self-esteem. Dermatol Surg. 2010;36(suppl 4):2088–2097. doi:10.1111/j.1524-4725.2010.01795.x
   PubMedGoogle Scholar
• Rivkin AZ, Ogilvie P, Dayan S, Yoelin SG, Weichman BM, Garcia JK. OnabotulinumtoxinA for simultaneous treatment of upper facial lines: subject-reported satisfaction and impact from a Phase 3 study. Dermatol Surg. 2020;46(1):50–60. doi:10.1097/DSS.0000000000001883
   PubMed Web of Science ®Google Scholar
• Dayan S, Coleman WP, Dover JS, et al. Effects of onabotulinumtoxinA treatment for crow’s feet lines on patient-reported outcomes. Dermatol Surg. 2015;41(suppl 1):S67–S74. doi:10.1097/DSS.0000000000000146
   PubMed Web of Science ®Google Scholar
• The Aesthetic Society. Aesthetic Plastic Surgery National Databank Statistics 2020–2021; 2022. Available from: https://cdn.theaestheticsociety.org/media/statistics/2021-TheAestheticSocietyStatistics.pdf. Accessed May 2, 2022.
   Google Scholar
• Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science. 1998;282(5387):245–246. doi:10.1126/science.282.5387.245
   PubMed Web of Science ®Google Scholar
• Klassen AF, Cano SJ, Schwitzer JA, Scott AM, Pusic AL. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg. 2015;135(2):375–386. doi:10.1097/PRS.0000000000000895
   PubMed Web of Science ®Google Scholar
• Pompilus F, Burgess S, Hudgens S, Banderas B, Daniels S. Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: Facial Line Satisfaction Questionnaire. J Cosmet Dermatol. 2015;14(4):274–285. doi:10.1111/jocd.12166
   PubMed Web of Science ®Google Scholar
• Yaworsky A, Daniels S, Tully S, et al. The impact of upper facial lines and psychological impact of crow’s feet lines: content validation of the Facial Line Outcomes (FLO-11) Questionnaire. J Cosmet Dermatol. 2014;13(4):297–306. doi:10.1111/jocd.12117
   PubMed Web of Science ®Google Scholar
• Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res. 2009;18(1):115–123. doi:10.1007/s11136-008-9430-6
   PubMed Web of Science ®Google Scholar
• Narurkar V, Shamban A, Sissins P, Stonehouse A, Gallagher C. Facial treatment preferences in aesthetically aware women. Dermatol Surg. 2015;41(suppl 1):S153–S160. doi:10.1097/DSS.0000000000000293
   PubMedGoogle Scholar
• De Boulle K, Furuyama N, Heydenrych I, et al. Considerations for the use of minimally invasive aesthetic procedures for facial remodeling in transgender individuals. Clin Cosmet Invest Dermatol. 2021;2021(14):513–525. doi:10.2147/CCID.S304032
   Google Scholar
• Jagdeo J, Keaney T, Narurkar V, Kolodziejczyk J, Gallagher CJ. Facial treatment preferences among aesthetically oriented men. Dermatol Surg. 2016;42(10):1155–1163. doi:10.1097/DSS.0000000000000876
   PubMed Web of Science ®Google Scholar
• Alam M, Tung R. Injection technique in neurotoxins and fillers: planning and basic technique. J Am Acad Dermatol. 2018;79(3):407–419. doi:10.1016/j.jaad.2018.01.034
   PubMed Web of Science ®Google Scholar
• Nair AG, Santhanam A. Clinical photography for periorbital and facial aesthetic practice. J Cutan Aesthet Surg. 2016;9(2):115–121. doi:10.4103/0974-2077.184047
   PubMedGoogle Scholar
• Humphrey S. Neurotoxins: evidence for prevention. J Drugs Dermatol. 2017;16(6):s87–s90.
   PubMedGoogle Scholar
• Mobayed N, Nguyen JK, Jagdeo J. Minimally invasive facial cosmetic procedures for the millennial aesthetic patient. J Drugs Dermatol. 2020;19(1):100–103. doi:10.36849/JDD.2020.4641
   PubMed Web of Science ®Google Scholar
• Bonati LM, Fabi SG. Treating the young aesthetic patient: evidence-based recommendations. J Drugs Dermatol. 2017;16(6):s81–s83.
   PubMedGoogle Scholar
• UK Department of Health and Social Care. Botulinum toxin and cosmetic fillers for under 18s; 2021. Available from: https://www.gov.uk/government/publications/botulinum-toxin-and-cosmetic-fillers-for-under-18s. Accessed September 29, 2023.
   Google Scholar
• Carruthers J, Fagien S, Matarasso SL. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg. 2004;114(6 suppl):1S–22S. doi:10.1097/01.PRS.0000144795.76040.D3
   PubMed Web of Science ®Google Scholar
• Hallett M. Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon. 2015;107(Pt A):64–67. doi:10.1016/j.toxicon.2015.07.013
   PubMedGoogle Scholar
• Flynn TC. Botulinum toxin: examining duration of effect in facial aesthetic applications. Am J Clin Dermatol. 2010;11(3):183–199. doi:10.2165/11530110-000000000-00000
   PubMed Web of Science ®Google Scholar
• Torres S, Hamilton M, Sanches E, Starovatova P, Gubanova E, Reshetnikova T. Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports. Clin Cosmet Invest Dermatol. 2014;7:11–17. doi:10.2147/CCID.S51938
   PubMedGoogle Scholar
• Jankovic J, Carruthers J, Naumann M, et al. Neutralizing antibody formation with OnabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis. Toxins. 2023;15(5):342. doi:10.3390/toxins15050342
   PubMed Web of Science ®Google Scholar
• Cohen JL, Goodman GJ, De Almeida AT, et al. Decades of beauty: achieving aesthetic goals throughout the lifespan. J Cosmet Dermatol. 2023;22(11):2889–2901. doi:10.1111/jocd.15968
   PubMedGoogle Scholar
• Fabi S, Alexiades M, Chatrath V, et al. Facial aesthetic priorities and concerns: a physician and patient perception global survey. Aesthet Surg J. 2022;42(4):NP218–NP229. doi:10.1093/asj/sjab358
   PubMed Web of Science ®Google Scholar
• Klassen AF, Cano SJ, Scott A, Snell L, Pusic AL. Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg. 2010;26(4):303–309. doi:10.1055/s-0030-1262313
   PubMed Web of Science ®Google Scholar
• Liew S, Silberberg M, Chantrey J. Understanding and treating different patient archetypes in aesthetic medicine. J Cosmet Dermatol. 2020;19(2):296–302. doi:10.1111/jocd.13227
   PubMed Web of Science ®Google Scholar
• Smit R, Gubanova E, Kaufman J, et al. Patient satisfaction with abobotulinumtoxinA for aesthetic use in the upper face: a systematic literature review and post-hoc analysis of the APPEAL study. J Clin Aesthet Dermatol. 2021;14(2):E69–E88.
   PubMedGoogle Scholar
• Cohen JL, Scuderi N. Safety and patient satisfaction of abobotulinumtoxinA for aesthetic use: a systematic review. Aesthet Surg J. 2017;37(suppl 1):S32–S44. doi:10.1093/asj/sjx010
   PubMedGoogle Scholar
• Nestor M, Ablon G, Pickett A. Key parameters for the use of abobotulinumtoxinA in aesthetics: onset and duration. Aesthet Surg J. 2017;37(suppl 1):S20–S31. doi:10.1093/asj/sjw282
   PubMedGoogle Scholar
• Ching S, Thoma A, McCabe RE, Antony MM. Measuring outcomes in aesthetic surgery: a comprehensive review of the literature. Plast Reconstr Surg. 2003;111(1):469–480. doi:10.1097/00006534-200301000-00085
   PubMed Web of Science ®Google Scholar
• Kim WJ, Kumthornthip W, Oh BM, Yang EJ, Paik NJ. Feasibility of video clip analysis on effect of botulinum toxin-A injection for post-stroke upper limb spasticity. Toxins. 2013;5(5):983–991. doi:10.3390/toxins5050983
   PubMed Web of Science ®Google Scholar
• Wang J, Rieder EA. A systematic review of patient-reported outcomes for cosmetic indications of botulinum toxin treatment. Dermatol Surg. 2019;45(5):668–688. doi:10.1097/DSS.0000000000001878
   PubMed Web of Science ®Google Scholar